Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001193125-26-264004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
37,152
Total Value
$33,880.00
P&L
+1865.1% (+$631,883.84)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 8, 2026 | Purchase | 2,000 | $16.94 | $33,880.00 | 24,500 | Direct | โ | View Details | |
Director | Stock option (right to buy) | Derivative | Jun 5, 2026 | Grant/Award | 35,152 | $0.00 | $0.00 | 35,152 | Direct | โ | View Details |